medigraphic.com
SPANISH

Revista Médica Electrónica

ISSN 1684-1824 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 2

<< Back Next >>

Rev Méd Electrón 2019; 41 (2)

Bipolar disorder. Clinical and epidemiologic characteristics

Martínez HO, Montalván MO, Betancourt IY
Full text How to cite this article

Language: Spanish
References: 42
Page: 467-482
PDF size: 819.87 Kb.


Key words:

bipolar disorder, epidemiology, suicide, co-morbidity.

ABSTRACT

Bipolar disorder is a chronic and recurrent disorder characterized by pathological fluctuations of the mood states. The stages of the disease include hypomanic, maniac and depressive episodes. These episodes interfere in a significant way in the patient´s daily life and his surroundings, with an important repercussion on his health and life quality. For the psychiatrists, the precocious diagnosis of this disease is very important, in order to provide a timely treatment to patients, taking into account the severity of the symptoms and the complications of this disease. Due to this reality, the authors decided to describe the general characteristics of this disorder through a bibliographic review where they exposed the main clinical manifestations, classification, epidemiological aspects, the course of the disease, complications and co-morbidity. The most relevant published works were reviewed to contribute to the process of continued medical education of the health professionals.


REFERENCES

  1. Belmaker R. Bipolar disorder [Internet].N Engl J Med. 2004 [citado 23/04/2017];351:476–86. Disponible en: https://www.nejm.org/doi/full/10.1056/nejmra035354

  2. World Health Organization. The global burden of disease. 2004 update[Internet]. USA: World Health Organization [citado 12/04/2017];2004. Disponible en: https://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/

  3. Pedrosa PD, Torres LJL, González MO, et al. Consideraciones actuales del espectro de enfermedad bipolar. Rev Hospital Psiquiátrico de La Habana [Internet]. 2015 [citado 23/04/2017];12(3). Disponible en: http://www.medigraphic.com/cgibin/ new/resumen.cgi?IDARTICULO=64521

  4. Vázquez Gustavo H. Los trastornos bipolares hoy: más allá del DSM–5. Psicodebate [Internet]. 2014 [citado 23/05/2017];14(2):9–24. Disponible en: https://dspace.palermo.edu/ojs/index.php/psicodebate/article/view/353

  5. Martin DJ, Smith DJ. Is there a clinical prodrome of bipolar disorder? A review of the evidence. Expert Review of Neurotherapeutics 2014;13(1):89–98. Citado en PubMed: PMID:23253393.

  6. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;60(3):261–9. Citado en PubMed: PMID:12622659.

  7. Chávez-León E, Benítez-Camacho E, Ontiveros Uribe MP. La terapia cognitivo conductual en el tratamiento de la depresión del trastorno bipolar tipo I. Salud Mental [Internet]. 2014[citado 23/04/2017];37(2):111-17. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0185- 33252014000200004

  8. Jann M. Diagnosis and Treatment of Bipolar Disorders in Adults: A Review of the Evidence on Pharmacologic Treatments. Am Health Drug Benefits. 2014;7(9):489– 99. Citado en PubMed: PMID: 25610528.

  9. NIH. Bipolar Disorder [Internet]. USA: National Institute of Mental Health[citado 01/10/2016];2014. Disponible en: https://www.nimh.nih.gov/health/publications/bipolar-disorder/index.shtml

  10. Mendoza L, Galindo JR, Munguia JC. Elementos predictores del Trastorno Bipolar. Rev Hondureña de Posgrado de Psiquiatría [Internet]. 2016[citado 23/06/2017];(2):73-81. Disponible en: http://www.bvs.hn/RHPP/pdf/2016/pdf/Vol10-2-2016-5.pdf

  11. Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2001;68(3):241-51. Citado en PubMed: PMID:21383262.

  12. Malhi GS, Bargh DM, Coulston CM, et al. Predicting bipolar disorder on the basis of phenomenology: Implications for prevention and early intervention. Bipolar Disord. 2014;16(5):455–70. Citado en PubMed: PMID:24636153.

  13. Baldessarini R, Tondo L, Vázquez G, et al. Onsetage versus family history and clinical outcomes in 1665 international bipolarI disorder patients. World Psychiatry. 2012;11(1):40–46. Citado en PubMed: PMID:22295008.

  14. Goodwin FK, Jaminson KR. Manic-Depressive Illness: Bipolar disorders and recurrent depression [Internet]. New York: Oxford University Press [citado 29/04/2017];2007. Disponible en: https://global.oup.com/academic/product/manic-depressive-illness- 9780195135794?cc=us&lang=en&

  15. Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2024;13(2):153–60. Citado en PubMed :PMID:24890068.

  16. Vieta E, Salagre E, Grande I, et al. Early Intervention in Bipolar Disorder. Am J Psychiatry. 2018;175(5). Citado en PubMed; PMID:29361850

  17. Kapczinski F, Magalhães PVS, Balanzá‐Martínez V, et al. Staging systems in bipolar disorder: an I nternational Society for Bipolar D isorders Task Force Report. Acta Psychiatr Scand. 2014;130(5):354-63. Citado en PubMed :PMID:24961757.

  18. Rosa Adriane R, Magalhaes PV, Czepielewski L, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clinical Psychiatry. 2014;75(5): e450-6. Citado en PubMed :PMID:24922497.

  19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders[Internet]. USA: American Psychiatric Association[citado 29/4/2017]; 2018. Disponible en: https://www.psychiatry.org/psychiatrists/practice/dsm

  20. Clasificación Internacional de enfermedades 10. Trastornos mentales y del comportamiento. Descripciones clínicas y pautas para el diagnóstico [Internet]. Madrid:MEDITOR [citado 29/12/2017]; 1992. Disponible en: https://apps.who.int/iris/handle/10665/40510

  21. Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry 2001;158(8):1265-70. Citado en PubMed :PMID:11481161.

  22. Perlis RH, Miyahara S, Marangell LB, et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55(9):875-81. Citado en PubMed; PMID:15110730

  23. Regeer EJ, Kupka RW, Have MT, et al. Low self-recognition and awareness of pasthypomanic and manic episodes in the general population. Int J Bipolar Disord.2015;3(1):22. Citado en PubMed; PMID: 26440507.

  24. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manicdepressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64(2):161-74. Citado en PubMed; PMID 12633125.

  25. Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry. 2002;63(1):985-91. Citado en PubMed; PMID:12444811.

  26. Pini S, de Queiroz V, Pagnin D, et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol. 2005;15(4):425–34. Citado en PubMed; PMID:15935623.

  27. García-Blanco AC, Sierra P, Livianos L. Nosología, epidemiología y etiopatogenia del trastorno bipolar: Últimas aproximaciones. Psiquiatría Biológica[Internet]. 2014 [citado 25/11/2017];21(3):89–94. Disponible en: https://www.elsevier.es/esrevista- psiquiatria-biologica-46-articulo-nosologia-epidemiologia-etiopatogenia-deltrastorno- S1134593414000670?code=Y2gw1z6NP50ByKnGtbC9dXm3jAIcZ7&newsletter=true

  28. Yatham L, Kennedy S, Berk M, et al. Recomendaciones Fundamentadas y Actualizadas para el Tratamiento de los Pacientes con Trastorno Bipolar. Bipolar Disorders [Internet]. 2018[citado 27/11/2017]; 20(2):97-104. Disponible en: https://www.siicsalud.com/dato/resiic.php/157818

  29. Anderson IM, Haddad PM, Scott J. Actualización de su diagnóstico y tratamiento Trastorno bipolar. BMJ [Internet].2012 [citado 22/04/2017];345:e8508. Disponible en: https://www.intramed.net/contenidover.asp?contenidoID=78925

  30. Akiskal H, Cetkovich Bakmas M, et al. Trastornos bipolares. Conceptos clínicos, neurobiológicos y terapéuticos. Buenos Aires: Editorial Médica Panamericana; 2006.

  31. Ghaemi SN, Dalley S. The Bipolar Spectrum: conceptions and misconceptions. Aust N Z J Psychiatry. 2014;48(4):314-24. Citado en PubMed; PMID:24610031.

  32. Steele MM,DoeyT. Suicidal behaviour in children and adolescents. Part 1: etiology and risk factors. Can J Psychiatry. 2007;52(1):21S-33S. Citado en PubMed; PMID: 17824350.

  33. Carrà G, Bartoli F, Crocamo C, et al. Attempted suicide in people with cooccurring bipolar and substance use disorders: systematic review and metaanalysis. J Affect Disord. 2014;167:125-35. Citado en PubMed; PMID:24955564

  34. Zarabanda Suárez M, García Montes M, Salcedo Jarabo D, et al. Programa de formación médica continuada. Medicine [Internet]. 2015 [citado 23/04/2017];11(85):5075-85. Disponible en: https://www.sciencedirect.com/journal/medicine-programa-de-formacion-medicacontinuada- acreditado

  35. Judd LL, Akiskal HS, Schettler PJ, et al. The longterm natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530. Citado en PubMed; PMID:12044195

  36. Szeman N, Martínez-Raga J. Dual Disorders: Two different mental disorder? Adv Dual Diagn [Internet]. 2015 [citado 23/04/2018];8(2). Disponible en: https://www.researchgate.net/publication/274374931_Dual_disorders_two_differen t_mental_disorders

  37. Arias F, Szerman N, Vega P, et al. Trastorno bipolar y trastorno por uso de sustancias. Estudio Madrid sobre prevalencia de patología dual. Rev Adicciones [Internet]. 2017 [citado 19/04/2018];29(3):186-94. Disponible en: http://www.adicciones.es/index.php/adicciones/article/view/782

  38. Secades- Álvarez A, Fernández Rodríguez C. Revisión de la eficacia de los tratamientos para el trastorno bipolar en comorbildad con el abuso de sustancias. Rev Psiquiatría y Salud Mental [Internet]. 2017 [citado 29/04/2018];2(10):113-24. Disponible en: https://www.elsevier.es/es-revista-revista-psiquiatria-salud-mental- 286-articulo-revision-eficacia-los-tratamientos-el-S1888989115001640

  39. Carmiol N, Peralta JM, Almasy L, et al. Shared genetic factors influence risk for bipolar disorder and alcohol use disorders. Eur Psychiatry. 2014;29(5):282-87. Citado en PubMed; PMID:24321773.

  40. Hidalgo-Mazzei D, Walsh E, Rosenstein L, et al. Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Use Disorder. J Nerv Ment Dis. 2015;203(1):54-57. Citado en PubMed; PMID:25494335.

  41. Álvarez Ruiz EM, Gutiérrez Rojas L. Comorbilidad entre el trastorno bipolar y los trastornos de la conducta alimentaria. Rev Psiquiatría y Salud Mental [Internet]. 2015 [citado 29/4/2018];8(4):232-41. Disponible en: https://medes.com/publication/105354

  42. Soler Martínez AM, Giménez Giménez LM, Ruiz García BM, et al. Comorbilidad en pacientes con trastorno bipolar. Análisis por grupo de edad. XVI Congreso Virtual Internacional de Psiquiatría. Interpsiquis[Internet]. 2015 [citado 29/04/2018];Vol.XVI. Disponible en: https://psiquiatria.com/bibliopsiquis/comorbilidad-en-pacientes-con-trastornobipolar-analisis-por-grupo-de-edad/




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Méd Electrón. 2019;41